Suppr超能文献

丁丙诺啡:一种在阿片类药物成瘾治疗中作用不断扩大的镇痛药。

Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.

作者信息

Robinson Susan E

机构信息

Department of Pharmacology and Toxicology, P O Box 980613, Virginia Commonwealth University, Richmond, VA 23298-0613, USA.

出版信息

CNS Drug Rev. 2002 Winter;8(4):377-90. doi: 10.1111/j.1527-3458.2002.tb00235.x.

Abstract

Buprenorphine, a long-acting opioid with both agonist and antagonist properties, binds to mu-opioid (OP(3)), kappa-opioid (OP(2)), delta-opioid (OP(1)), and nociceptin (ORL-1) receptors. Its actions at these receptors have not been completely characterized, although buprenorphine is generally regarded as a mu-opioid receptor partial agonist and a kappa-opioid receptor antagonist. Its pharmacology is further complicated by an active metabolite, norbuprenorphine. Although buprenorphine can be used as an analgesic agent, it is of greater importance in the treatment of opioid abuse. Because of its partial agonist activity at mu-opioid receptors and its long half-life, buprenorphine has proven to be an excellent alternative to methadone for either maintenance therapy or detoxification of the opioid addict. Although buprenorphine may ultimately prove to be superior to methadone in the maintenance of the pregnant addict, its effects on the developing fetus must be carefully evaluated.

摘要

丁丙诺啡是一种具有激动剂和拮抗剂特性的长效阿片类药物,可与μ阿片受体(OP(3))、κ阿片受体(OP(2))、δ阿片受体(OP(1))和孤啡肽(ORL-1)受体结合。尽管丁丙诺啡通常被视为μ阿片受体部分激动剂和κ阿片受体拮抗剂,但其在这些受体上的作用尚未完全明确。其活性代谢产物去甲丁丙诺啡使丁丙诺啡的药理学特性更为复杂。尽管丁丙诺啡可用作镇痛药,但它在阿片类药物滥用治疗中更为重要。由于丁丙诺啡在μ阿片受体上具有部分激动剂活性且半衰期长,已证明它是美沙酮用于阿片类成瘾者维持治疗或脱毒的极佳替代品。尽管丁丙诺啡最终可能被证明在维持妊娠成瘾者方面优于美沙酮,但必须仔细评估其对发育中胎儿的影响。

相似文献

1
Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.
CNS Drug Rev. 2002 Winter;8(4):377-90. doi: 10.1111/j.1527-3458.2002.tb00235.x.
4
Buprenorphine for opioid dependence.
J Pain Palliat Care Pharmacother. 2009;23(2):153-5. doi: 10.1080/15360280902900869.
5
Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects.
CNS Drug Rev. 2002 Winter;8(4):391-404. doi: 10.1111/j.1527-3458.2002.tb00236.x.
7
Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
J Pharmacol Exp Ther. 2003 Jul;306(1):394-400. doi: 10.1124/jpet.103.048835. Epub 2003 Apr 29.
8
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
Addiction. 2012 Nov;107 Suppl 1(0 1):5-27. doi: 10.1111/j.1360-0443.2012.04035.x.

引用本文的文献

2
Dysphagia as a Missing Link Between Post-surgical- and Opioid-Related Pneumonia.
Lung. 2024 Apr;202(2):179-187. doi: 10.1007/s00408-024-00672-8. Epub 2024 Mar 27.
3
Serotonin therapies for opioid-induced disordered swallow and respiratory depression.
J Appl Physiol (1985). 2024 Apr 1;136(4):821-843. doi: 10.1152/japplphysiol.00509.2023. Epub 2024 Feb 22.
4
An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine.
Pharmaceuticals (Basel). 2023 Oct 2;16(10):1397. doi: 10.3390/ph16101397.
7
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.
Adv Drug Alcohol Res. 2021;1. doi: 10.3389/adar.2021.10009. Epub 2021 Aug 3.
8
Benefit-Risk Analysis of Buprenorphine for Pain Management.
J Pain Res. 2021 May 24;14:1359-1369. doi: 10.2147/JPR.S305146. eCollection 2021.
9
A review of the existing literature on buprenorphine pharmacogenomics.
Pharmacogenomics J. 2021 Apr;21(2):128-139. doi: 10.1038/s41397-020-00198-1. Epub 2020 Nov 5.
10
Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain.
J Pain Res. 2019 Dec 13;12:3299-3317. doi: 10.2147/JPR.S231948. eCollection 2019.

本文引用的文献

1
Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny.
Neurotoxicol Teratol. 2002 Mar-Apr;24(2):137-42. doi: 10.1016/s0892-0362(01)00185-4.
2
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
Psychopharmacology (Berl). 2002 Jan;159(2):161-6. doi: 10.1007/s002130100920. Epub 2001 Oct 12.
3
Opioid dependence treatment, including buprenorphine/naloxone.
Ann Pharmacother. 2002 Feb;36(2):312-21. doi: 10.1345/aph.10421.
5
[Buprenorphine in pregnancy].
Psychiatr Prax. 2001 Sep;28(6):267-9. doi: 10.1055/s-2001-16875.
6
Rapid heroin detoxification using a single high dose of buprenorphine.
J Psychoactive Drugs. 2001 Apr-Jun;33(2):191-3. doi: 10.1080/02791072.2001.10400484.
7
Effect of perinatal buprenorphine exposure on development in the rat.
J Pharmacol Exp Ther. 2001 Aug;298(2):797-804.
8
A meta-analysis comparing the effectiveness of buprenorphine and methadone.
J Subst Abuse. 2000;12(4):405-14. doi: 10.1016/s0899-3289(01)00054-2.
9
Gradual dose taper following chronic buprenorphine.
Am J Addict. 2001 Spring;10(2):111-21. doi: 10.1080/105504901750227778.
10
Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.
Neuropsychopharmacology. 2001 Jul;25(1):41-54. doi: 10.1016/S0893-133X(00)00252-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验